Profile data is unavailable for this security.
About the company
PT Organon Pharma Indonesia Tbk is an independent global healthcare company. It provides pharmaceutical products for women. Its segments are manufacturing and commercial. Its activities include manufacturing and processing medicines and health/food supplements in finished form for humans, including tablets, capsules, ointments, powders, solutions, parenteral solutions, and suspensions. It also produces hormonal contraceptive drugs. The Company engages in radiopharmaceutical production. It manufactures industrial medical dressings, bandages, and cosmetic cotton. It also engages in wholesale trade of laboratory, pharmaceutical, and medical equipment for humans. Its diverse portfolio of women's health, biosimilars, and established brands includes therapies and products for various conditions and diseases. Its products include ASMANEX HFA (mometasone furoate) inhalation aerosol for oral inhalation use, Jada System, Ganirelix Acetate Injection, and others.
- Revenue in IDR (TTM)3.55tn
- Net income in IDR244.62bn
- Incorporated1972
- Employees173.00
- LocationOrganon Pharma Indonesia Tbk PTGedung Wisma BNI 46Lantai 27 Jln Jendral Sudirman Kav.1JAKARTA SELATAN 12920IndonesiaIDN
- Phone+62 2 157897000
- Fax+62 2 131107009
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calmer Co International Ltd | 95.73bn | -47.57bn | 145.76bn | -- | -- | 6.33 | -- | 1.52 | -0.0015 | -0.0015 | 0.0029 | 0.0006 | 1.60 | 3.29 | 14.33 | -- | -79.73 | -109.82 | -171.17 | -197.50 | 42.49 | 41.18 | -49.69 | -128.71 | 1.22 | -11.32 | 0.5482 | -- | 88.48 | 59.99 | -7.13 | -- | 27.67 | -- |
| Gelteq Ltd | 1.97bn | -79.17bn | 145.94bn | 7.00 | -- | 0.7751 | -- | 73.95 | -0.4993 | -0.4993 | 0.0125 | 1.05 | 0.0078 | -- | 0.5155 | 16,780.32 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| Epsilon Healthcare Ltd | 73.07bn | -72.96bn | 146.45bn | -- | -- | -- | -- | 2.00 | -0.0164 | -0.0164 | 0.0167 | -0.0097 | 0.462 | -- | 4.95 | -- | -46.14 | -33.37 | -156.14 | -46.46 | 52.23 | 49.34 | -99.85 | -136.16 | 0.3775 | -3.92 | 1.67 | -- | -15.81 | 3.16 | -403.56 | -- | -32.83 | -- |
| cbdMD Inc | 322.40bn | -73.51bn | 150.28bn | 42.00 | -- | 1.05 | -- | 0.4661 | -3.92 | -3.92 | 4.77 | 0.8104 | 1.83 | 2.83 | 18.96 | -- | -19.44 | -48.27 | -44.42 | -54.99 | 62.37 | 63.95 | -10.63 | -85.60 | 1.20 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Cuprina Holdings (Cayman) Ltd | 402.86m | -37.61bn | 150.49bn | 14.00 | -- | 1.48 | -- | 373.57 | -0.1231 | -0.1231 | 0.0013 | 0.2828 | 0.0049 | 13.39 | 0.7976 | 1,712.73 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Organon Pharma Indonesia Tbk PT | 3.55tn | 244.62bn | 152.69bn | 173.00 | -- | -- | 0.5529 | 0.043 | 67,951.15 | 67,951.15 | 985,755.10 | 353,052.60 | 1.83 | 5.46 | 5.54 | 19,498,450,000.00 | 12.61 | 12.45 | 20.63 | 18.05 | 10.58 | 11.52 | 6.89 | 6.80 | 1.46 | 96.91 | 0.0007 | -- | 5.40 | 9.48 | -0.5787 | 10.62 | 14.01 | -- |
| Oncosil Medical Ltd | 15.03bn | -179.91bn | 153.06bn | 2.00 | -- | 3.13 | -- | 10.18 | -1.37 | -1.37 | 0.1148 | 0.217 | 0.182 | -- | 2.18 | -- | -217.79 | -97.54 | -382.54 | -117.83 | -78.62 | -54.05 | -1,196.80 | -1,258.41 | -- | -146.89 | 0.022 | -- | 116.34 | -15.15 | -26.74 | -- | -6.31 | -- |
| Vaishali Pharma Ltd | 217.24bn | -714.53m | 158.14bn | -- | 24.47 | 1.54 | 494.11 | 0.728 | 0.3258 | 0.3258 | 11.82 | 5.16 | 1.04 | 54.91 | 2.48 | -- | -0.3418 | 3.19 | -0.5293 | 6.67 | 11.29 | 15.64 | -0.3289 | 3.43 | 2.33 | -1.59 | 0.188 | -- | 14.77 | 10.51 | 13.70 | 90.26 | 42.08 | -- |
| Biofrontera Inc | 624.37bn | -295.21bn | 158.57bn | 92.00 | -- | -- | -- | 0.2540 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Zenith Drugs Ltd | 266.28bn | 6.99bn | 158.72bn | 182.00 | 22.71 | 1.20 | 9.46 | 0.5961 | 2.20 | 2.20 | 83.88 | 41.82 | 0.9315 | 2.80 | 2.33 | 7,903,775.00 | 2.45 | -- | 4.48 | -- | 33.80 | -- | 2.63 | -- | 0.9561 | 1.54 | 0.4198 | -- | 1.29 | -- | -24.92 | -- | -- | -- |
| Pharmacielo Ltd | 35.01bn | -79.53bn | 161.49bn | 268.00 | -- | -- | -- | 4.61 | -0.0356 | -0.0356 | 0.0156 | -0.0795 | 0.1994 | 1.71 | 4.10 | -- | -45.28 | -- | -- | -- | 3.13 | -- | -227.15 | -- | 0.0907 | -3.01 | 6.18 | -- | -- | -- | -- | -- | -- | -- |
